skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:054835/0633   Pages: 16
Recorded: 01/06/2021
Attorney Dkt #:15803018-000002
Conveyance: RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS).
Total properties: 38
1
Patent #:
6201010
Issue Dt:
03/13/2001
Application #:
09538182
Filing Dt:
03/30/2000
Title:
Anticonvulsant derivatives useful in lowering blood pressure
2
Patent #:
6191163
Issue Dt:
02/20/2001
Application #:
09538185
Filing Dt:
03/30/2000
Title:
Anticonvulsant derivatives useful in lowering lipids
3
Patent #:
6362220
Issue Dt:
03/26/2002
Application #:
09538803
Filing Dt:
03/30/2000
Title:
Anticonvulsant derivatives useful in reducing blood glucose levels
4
Patent #:
6495154
Issue Dt:
12/17/2002
Application #:
09721412
Filing Dt:
11/21/2000
Title:
ON DEMAND ADMINISTRATION OF CLOMIPRAMINE AND SALTS THEREOF TO TREAT PREMATURE EJACULATION
5
Patent #:
6946141
Issue Dt:
09/20/2005
Application #:
09996407
Filing Dt:
11/21/2001
Publication #:
US20020161016
Pub Dt:
10/31/2002
Title:
AS-NEEDED ADMINISTRATION OF TRICYCLIC AND OTHER NON-SRI ANTIDEPRESSANT DRUGS TO TREAT PREMATURE EJACULATION
6
Patent #:
7056890
Issue Dt:
06/06/2006
Application #:
10454368
Filing Dt:
06/03/2003
Publication #:
US20040002462
Pub Dt:
01/01/2004
Title:
COMBINATION THERAPY FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY
7
Patent #:
7553818
Issue Dt:
06/30/2009
Application #:
11385198
Filing Dt:
03/20/2006
Publication #:
US20060234950
Pub Dt:
10/19/2006
Title:
COMBINATION THERAPY FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY
8
Patent #:
7659256
Issue Dt:
02/09/2010
Application #:
11385199
Filing Dt:
03/20/2006
Publication #:
US20060234951
Pub Dt:
10/19/2006
Title:
COMBINATION THERAPY FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY
9
Patent #:
7474776
Issue Dt:
01/06/2009
Application #:
11613283
Filing Dt:
12/20/2006
Publication #:
US20070167718
Pub Dt:
07/19/2007
Title:
SYSTEM AND METHOD FOR PERFORMING A THREE-DIMENTIONAL VIRTUAL EXAMINATION OF OBJECTS, SUCH AS INTERNAL ORGANS
10
Patent #:
8071557
Issue Dt:
12/06/2011
Application #:
11818306
Filing Dt:
06/13/2007
Publication #:
US20080312163
Pub Dt:
12/18/2008
Title:
TREATMENT OF PULMONARY HYPERTENSION WITH CARBONIC ANHYDRASE INHIBITORS
11
Patent #:
8580298
Issue Dt:
11/12/2013
Application #:
12481540
Filing Dt:
06/09/2009
Publication #:
US20100215739
Pub Dt:
08/26/2010
Title:
LOW DOSE TOPIRAMATE / PHENTERMINE COMPOSITION AND METHODS OF USE THEREOF
12
Patent #:
8580299
Issue Dt:
11/12/2013
Application #:
12481548
Filing Dt:
06/09/2009
Publication #:
US20090304785
Pub Dt:
12/10/2009
Title:
ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY
13
Patent #:
8802636
Issue Dt:
08/12/2014
Application #:
12683353
Filing Dt:
01/06/2010
Publication #:
US20100105765
Pub Dt:
04/29/2010
Title:
COMBINATION THERAPY FOR TREATMENT OF SLEEP APNEA
14
Patent #:
8536138
Issue Dt:
09/17/2013
Application #:
13311476
Filing Dt:
12/05/2011
Publication #:
US20120196881
Pub Dt:
08/02/2012
Title:
Treatment Of Pulmonary Hypertension With Carbonic Anhydrase Inhibitors
15
Patent #:
8895057
Issue Dt:
11/25/2014
Application #:
14048416
Filing Dt:
10/08/2013
Publication #:
US20140187623
Pub Dt:
07/03/2014
Title:
Escalating Dosing Regimen For Effecting Weight Loss And Treating Obesity
16
Patent #:
8895058
Issue Dt:
11/25/2014
Application #:
14048576
Filing Dt:
10/08/2013
Publication #:
US20140037723
Pub Dt:
02/06/2014
Title:
Low Dose Topiramate/Phentermine Composition And Methods Of Use Thereof
17
Patent #:
9011905
Issue Dt:
04/21/2015
Application #:
14495246
Filing Dt:
09/24/2014
Publication #:
US20150010625
Pub Dt:
01/08/2015
Title:
Low Dose Topiramate/Phentermine Composition and Methods of Use Thereof
18
Patent #:
9011906
Issue Dt:
04/21/2015
Application #:
14495250
Filing Dt:
09/24/2014
Publication #:
US20150010626
Pub Dt:
01/08/2015
Title:
ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY
19
Patent #:
9724327
Issue Dt:
08/08/2017
Application #:
14509297
Filing Dt:
10/08/2014
Publication #:
US20150099801
Pub Dt:
04/09/2015
Title:
METHODS OF PREVENTING PROGRESSION TO TYPE 2 DIABETES MELLITUS
20
Patent #:
10028916
Issue Dt:
07/24/2018
Application #:
14714028
Filing Dt:
05/15/2015
Publication #:
US20160331687
Pub Dt:
11/17/2016
Title:
ORALLY DISINTEGRATING DOSAGE FORM FOR ADMINISTRATION OF AVANAFIL, AND ASSOCIATED METHODS OF MANUFACTURE AND USE
21
Patent #:
10058532
Issue Dt:
08/28/2018
Application #:
15639972
Filing Dt:
06/30/2017
Publication #:
US20180055818
Pub Dt:
03/01/2018
Title:
METHODS OF PREVENTING PROGRESSION TO TYPE 2 DIABETES MELLITUS
22
Patent #:
NONE
Issue Dt:
Application #:
15795073
Filing Dt:
10/26/2017
Publication #:
US20180052975
Pub Dt:
02/22/2018
Title:
METHODS OF REGULATING ACCESS TO QSYMIA TO MITIGATE POTENTIAL DRUG-ASSOCIATED RISKS
23
Patent #:
NONE
Issue Dt:
Application #:
16007420
Filing Dt:
06/13/2018
Publication #:
US20190142786
Pub Dt:
05/16/2019
Title:
METHODS OF TREATING OBESITY IN RESPONDER AND NON-RESPONDER POPULATIONS
24
Patent #:
NONE
Issue Dt:
Application #:
16008808
Filing Dt:
06/14/2018
Publication #:
US20190139635
Pub Dt:
05/09/2019
Title:
METHODS OF REGULATING ACCESS TO QSYMIA TO MITIGATE POTENTIAL DRUG-ASSOCIATED RISKS
25
Patent #:
NONE
Issue Dt:
Application #:
16014093
Filing Dt:
06/21/2018
Publication #:
US20190133955
Pub Dt:
05/09/2019
Title:
ORALLY DISINTEGRATING DOSAGE FORM FOR ADMINISTRATION OF AVANAFIL, AND ASSOCIATED METHODS OF MANUFACTURE AND USE
26
Patent #:
NONE
Issue Dt:
Application #:
16026886
Filing Dt:
07/03/2018
Publication #:
US20190167633
Pub Dt:
06/06/2019
Title:
COMBINATION THERAPY FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY
27
Patent #:
NONE
Issue Dt:
Application #:
16049989
Filing Dt:
07/31/2018
Publication #:
US20190201374
Pub Dt:
07/04/2019
Title:
METHODS OF PREVENTING PROGRESSION TO TYPE 2 DIABETES MELITUS
28
Patent #:
NONE
Issue Dt:
Application #:
16108396
Filing Dt:
08/22/2018
Publication #:
US20190209595
Pub Dt:
07/11/2019
Title:
ORALLY ADMINISTRABLE FORMULATIONS FOR THE CONTROLLED RELEASE OF A PHARMACOLOGICALLY ACTIVE AGENT
29
Patent #:
NONE
Issue Dt:
Application #:
16220269
Filing Dt:
12/14/2018
Publication #:
US20190350866
Pub Dt:
11/21/2019
Title:
LOW DOSE TOPIRAMATE/PHENTERMINE COMPOSITION AND METHODS OF USE THEREOF
30
Patent #:
NONE
Issue Dt:
Application #:
16220276
Filing Dt:
12/14/2018
Publication #:
US20190350897
Pub Dt:
11/21/2019
Title:
ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY
31
Patent #:
NONE
Issue Dt:
Application #:
16251231
Filing Dt:
01/18/2019
Publication #:
US20190374505
Pub Dt:
12/12/2019
Title:
METHODS AND COMPOSITIONS FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
32
Patent #:
NONE
Issue Dt:
Application #:
16296436
Filing Dt:
03/08/2019
Publication #:
US20200069716
Pub Dt:
03/05/2020
Title:
TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST
33
Patent #:
NONE
Issue Dt:
Application #:
16360114
Filing Dt:
03/21/2019
Publication #:
US20200054613
Pub Dt:
02/20/2020
Title:
COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF PULMONARY HYPERTENSION
34
Patent #:
NONE
Issue Dt:
Application #:
16381128
Filing Dt:
04/11/2019
Publication #:
US20200069658
Pub Dt:
03/05/2020
Title:
COMBINATION THERAPY FOR PULMONARY HYPERTENSION
35
Patent #:
NONE
Issue Dt:
Application #:
16590703
Filing Dt:
10/02/2019
Publication #:
US20200030239
Pub Dt:
01/30/2020
Title:
ORALLY DISINTEGRATING DOSAGE FORM FOR ADMINISTRATION OF AVANAFIL, AND ASSOCIATED METHODS OF MANUFACTURE AND USE
36
Patent #:
NONE
Issue Dt:
Application #:
16732508
Filing Dt:
01/02/2020
Publication #:
US20200135318
Pub Dt:
04/30/2020
Title:
METHODS OF REGULATING ACCESS TO QSYMIA TO MITIGATE POTENTIAL DRUG-ASSOCIATED RISKS
37
Patent #:
NONE
Issue Dt:
Application #:
16732544
Filing Dt:
01/02/2020
Publication #:
US20200129474
Pub Dt:
04/30/2020
Title:
COMBINATION THERAPY FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY
38
Patent #:
NONE
Issue Dt:
Application #:
16733559
Filing Dt:
01/03/2020
Publication #:
US20200179332
Pub Dt:
06/11/2020
Title:
METHODS OF PREVENTING PROGRESSION TO TYPE 2 DIABETES MELITUS
Assignor
1
U.S. BANK NATIONAL ASSOCIATION
Exec Dt:
12/11/2020
Assignee
1
VIVUS, INC.
900 EAST HAMILTON AVENUE, SUITE 550
CAMPBELL, CALIFORNIA 95008
Correspondence name and address
DENTONS US LLP
P. O. BOX 061080
WACKER DRIVE STATION, WILLIS TOWER
CHICAGO, IL 60606

Search Results as of: 06/27/2024 07:02 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT